Cargando…
Identification of a NACC1-Regulated Gene Signature Implicated in the Features of Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), characterized by a deficiency in estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor2 (HER2), is among the most lethal subtypes of breast cancer (BC). Nevertheless, the molecular determinants that contribute to its mali...
Autores principales: | Ngule, Chrispus M., Hemati, Hami, Ren, Xingcong, Obaleye, Oluwafunminiyi, Akinyemi, Amos O., Oyelami, Felix F., Xiong, Xiaofang, Song, Jianxun, Liu, Xia, Yang, Jin-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136325/ https://www.ncbi.nlm.nih.gov/pubmed/37189841 http://dx.doi.org/10.3390/biomedicines11041223 |
Ejemplares similares
-
Unveiling the dark side of glucose-regulated protein 78 (GRP78) in cancers and other human pathology: a systematic review
por: Akinyemi, Amos Olalekan, et al.
Publicado: (2023) -
Co-Targeting Nucleus Accumbens Associate 1 and NF-κB Signaling Synergistically Inhibits Melanoma Growth
por: Gu, Lixiang, et al.
Publicado: (2023) -
Cell aggregation prevents anoikis and induces CD44 cleavage by maintaining lipid raft integrity to promote triple negative breast cancer metastasis
por: li, dong, et al.
Publicado: (2023) -
Portuguese version of the CDR plus NACC FTLD: Validation studies
por: Lima, Marisa, et al.
Publicado: (2022) -
ICAM-1-suPAR-CD11b Axis Is a Novel Therapeutic Target for Metastatic Triple-Negative Breast Cancer
por: Li, Dong, et al.
Publicado: (2023)